Clin2
NCT07328984Possibly a fitNot yet recruiting

Steroid Duration for Severe Pneumocystis Pneumonia

Pneumocystis PneumoniaPneumocystisPneumocystis Jirovecii InfectionPneumocystis Jiroveci PneumoniaPneumocystis Carinii; Infection, Resulting From HIV DiseasePneumocystosis Associated With AIDSPneumocystosis; Pneumonia (Etiology)

Part of Infections, Lungs & breathing clinical trials.

This trial is testing whether a shorter or longer course of steroids works better for people recovering from severe Pneumocystis pneumonia (a lung infection). If you are 18 or older and have been on steroids for about 10 days but no longer need extra oxygen, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
416 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older.
  • You have a moderate to severe case of Pneumocystis pneumonia (a lung infection common in people with weakened immune systems).
  • At the time of diagnosis, you needed extra oxygen (at least 4 liters per minute) to keep your oxygen levels normal.
  • You have already started or are about to start taking steroids (like prednisone) to treat the pneumonia.
  • After about 10 days of steroids, you are able to breathe normally without extra oxygen for at least 6 hours in a row.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04851015Recruiting· Phase 3
Low-dose TMP-SMX for Pneumocystis pneumonia (PCP)

This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.

Montreal, Quebec
NCT07152613Not yet recruiting· Phase 3
Steroids for Pneumocystis pneumonia in ICU adults without HIV

This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.

NCT03856229Enrolling by invitation
Short steroid treatment for lung infection from PCP in HIV

This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.

México, State of Mexico
NCT07357103Not yet recruiting· Phase 4
Comparing second-line treatments for pneumocystis pneumonia

This trial tests different antibiotics for people with pneumocystis pneumonia who cannot take the standard treatment. It aims to find the best alternative therapy.

NCT07357935Not yet recruiting· Phase 1/Phase 2
Steroid treatment for severe pneumonia in the ICU

This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.

NCT07199192Not yet recruiting· Phase 4
Steroid treatment for severe lung infections in hospitalized adults

This study tests whether giving steroids (a type of anti-inflammatory medicine) to adults hospitalized with severe respiratory infections can help them recover faster. If you have a serious lung infection and low oxygen levels, this trial may be an option for you.

Minneapolis, Minnesota

Hear when a new Pneumocystis Pneumonia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.